LINC00675 is a prognostic factor and regulates cell proliferation, migration and invasion in glioma

被引：12
|
作者：
Li, Zhibing [1 ]
Li, Yijian [2 ]
Wang, Qibai [3 ]
机构：
[1] Shanxi Prov Tumor Hosp, Dept Neurol, Taiyuan 030003, Shanxi, Peoples R China
[2] Tradit Chinese Med Hosp Juye Cty, Dept Surg 2, Heze 274900, Shandong, Peoples R China
[3] Jiangbei Dist Peoples Hosp, Hosp Chongqing Red Cross Soc, Dept Neurol, Chongqing 400025, Peoples R China
来源：
BIOSCIENCE REPORTS | 2018年 / 38卷
关键词：
EPITHELIAL-MESENCHYMAL TRANSITION; INDUCED APOPTOSIS; ADAPTER PROTEIN; TRIP6; PROMOTES; CANCER; OVEREXPRESSION; PROGRESSION; P27(KIP1);
D O I：
10.1042/BSR20181039
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
LINC00675 has been suggested to be dysregulated in gastric cancer, colorectal cancer and pancreatic cancer. However, the expression status and biological function of LINC00675 in glioma were still unknown. Thus, we reported LINC00675 was overexpressed in glioma tissues and cell lines, and positively associated with advanced WHO grade, large tumor size and poor prognosis. Moreover, univariate and multivariate analyses suggested that high-expression of LINC00675 was an independent unfavorable prognostic predictor for glioma. In addition, levels of LINC00675 expression were positively correlated with TRIP6 mRNA and protein expressions. The in vitro experiment showed that silencing of LINC00675 inhibits glioma cell proliferation, migration and invasion through regulating TRIP6. In conclusion, LINC00675 acts as a tumor promoter in glioma progression.
引用
收藏
页码：1 / 10
页数：10
相关论文
共 50 条
  • [1] The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer
    Ma, Shuyun
    Deng, Xiaohong
    Yang, Yang
    Zhang, Qingqing
    Zhou, Ting
    Liu, Zi
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 108 : 1686 - 1693
  • [2] LINC00675 suppresses proliferative, migration and invasion of clear cell renal cell carcinoma via the Wnt/β-catenin pathway
    Zhu, L.
    Liu, X-L
    Fu, Z-Q
    Qiu, P.
    Feng, T.
    Yan, B.
    Wei, J-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (05) : 2313 - 2320
  • [3] The clinical prognostic value of lncRNA LINC00675 in cancer patients A meta-analysis
    Hua, Hao
    Wang, Jie
    Zhong, Pingyong
    Mou, Tinggang
    Liu, Pan
    Xie, Fei
    MEDICINE, 2021, 100 (16)
  • [4] N6-Methyladenosine-regulated LINC00675 suppress the proliferation, migration and invasion of breast cancer cells via inhibiting miR-513b-5p
    Fan, Shenglan
    Wang, Liping
    BIOENGINEERED, 2021, 12 (02) : 10690 - 10702
  • [5] LINC00629 Regulates Cell Proliferation, Migration, Invasion and Apoptosis of Lung Adenocarcinoma
    He, S.
    Meng, M.
    Xing, S.
    Tian, X.
    Zhou, L.
    Zhang, Y.
    Shen, G.
    Zhang, T.
    Li, E.
    Zhang, L.
    Bai, Y.
    Ma, H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S435 - S436
  • [6] Long noncoding RNA LINC01296 regulates the cell proliferation, migration and invasion in neuroblastoma
    Xiao, Huiling
    Li, Yanhong
    Zhang, Ying
    Wang, Peng
    METABOLIC BRAIN DISEASE, 2022, 37 (04) : 1247 - 1258
  • [7] Long noncoding RNA LINC01296 regulates the cell proliferation, migration and invasion in neuroblastoma
    Huiling Xiao
    Yanhong Li
    Ying Zhang
    Peng Wang
    Metabolic Brain Disease, 2022, 37 : 1247 - 1258
  • [8] CXCR7 REGULATES GLIOMA CELL PROLIFERATION, MIGRATION, INVASION, AND TUMOR DEVELOPMENT
    Liu, Yang
    Carson-Walter, Eleanor B.
    Whiteman, Melissa
    Walter, Kevin A.
    NEURO-ONCOLOGY, 2009, 11 (05) : 589 - 589
  • [9] LINC00675 Suppresses Cell Proliferation and Migration via Downregulating the H3K4me2 Level at the SPRY4 Promoter in Gastric Cancer
    Pan, Yutian
    Fang, Yuan
    Xie, Mengyan
    Liu, Yu
    Yu, Tao
    Wu, Xi
    Xu, Tongpeng
    Ma, Pei
    Shu, Yongqian
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 22 : 766 - 778
  • [10] LINC01480 as a Prognostic Biomarker Associated With Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma
    Ma, Yan
    Wu, Chunyang
    Deng, Shixiong
    ANTICANCER RESEARCH, 2023, 43 (07) : 3037 - 3046
12345